1
00:00:00,200 --> 00:00:04,160
Speaker 1: David Seymour has released his Letter of Expectations for farm Act.

2
00:00:04,280 --> 00:00:07,960
Speaker 1: Following a significant funding boost, the drug buying agency has

3
00:00:08,000 --> 00:00:11,440
Speaker 1: been told it needs to deliver improved health outcomes underpinned

4
00:00:11,440 --> 00:00:16,000
Speaker 1: by robust data and evidence. Seymour has also told FARMAC

5
00:00:16,079 --> 00:00:19,040
Speaker 1: to halt the embedding of tetentity or white hanging in

6
00:00:19,079 --> 00:00:20,080
Speaker 1: its decision making.

7
00:00:20,680 --> 00:00:23,400
Speaker 2: If it treats me different New Zealand's differently based on

8
00:00:23,440 --> 00:00:25,520
Speaker 2: whether or not they had an ancestor who was Mari,

9
00:00:26,040 --> 00:00:27,360
Speaker 2: then we want nothing to do with it.

10
00:00:28,160 --> 00:00:30,760
Speaker 1: Malcolm R. Holland is the chair of the Patient Voice

11
00:00:30,800 --> 00:00:33,120
Speaker 1: outed our group and joins me now, Malcolm, welcome to

12
00:00:33,200 --> 00:00:36,640
Speaker 1: the program. First of all, this treaty exclusion does that

13
00:00:36,680 --> 00:00:38,280
Speaker 1: bother you?

14
00:00:38,280 --> 00:00:41,839
Speaker 2: No, it doesn't. There was never any evidence that by

15
00:00:41,920 --> 00:00:47,440
Speaker 2: having treaty provisions within farmac's decision making process that led

16
00:00:47,479 --> 00:00:50,400
Speaker 2: to MARDI access in more medicines. It was very unclear

17
00:00:50,440 --> 00:00:53,120
Speaker 2: as to how it was being used, so it made

18
00:00:53,520 --> 00:00:55,720
Speaker 2: from our perspective, no material difference.

19
00:00:56,040 --> 00:00:59,560
Speaker 1: Apart from that, what is new in this What gives

20
00:00:59,560 --> 00:01:03,280
Speaker 1: you hope that this is going to lead to actual change?

21
00:01:03,280 --> 00:01:07,280
Speaker 2: It is a number of things, probably in particular is

22
00:01:07,520 --> 00:01:12,200
Speaker 2: around looking at famic's dietritory objectives, So whether or not

23
00:01:12,360 --> 00:01:18,319
Speaker 2: they need to retain reference to FARMAC having a MILEFIC

24
00:01:18,400 --> 00:01:22,440
Speaker 2: process if you like, on cost containment, looking at the

25
00:01:22,520 --> 00:01:27,120
Speaker 2: health technology assessment process in for FARMAC to consider some

26
00:01:27,280 --> 00:01:29,759
Speaker 2: of the savings that can occur within the health system

27
00:01:29,800 --> 00:01:33,720
Speaker 2: and to the wider taxpayer as they found a particular medicine,

28
00:01:33,720 --> 00:01:36,320
Speaker 2: and also looking at the separation of roles between FARMAC

29
00:01:36,400 --> 00:01:39,280
Speaker 2: is a procurement agency as well as the Health Technology

30
00:01:39,319 --> 00:01:41,679
Speaker 2: Assessment Agency as well.

31
00:01:41,760 --> 00:01:43,760
Speaker 1: Okay, so there's stuff in there that gives you a

32
00:01:43,760 --> 00:01:46,800
Speaker 1: bit of hope. How do you think FARMAC will respond

33
00:01:46,840 --> 00:01:49,120
Speaker 1: to this? Do you think that they're up to the job.

34
00:01:50,600 --> 00:01:54,680
Speaker 2: Well, it was interesting being there yesterday. Certainly, the conversations

35
00:01:54,680 --> 00:01:57,120
Speaker 2: that we had with FAMAIC staff, they seemed overall positive.

36
00:01:58,360 --> 00:02:00,680
Speaker 2: You know, I believe there was a bit of reluctance

37
00:02:00,760 --> 00:02:04,240
Speaker 2: around the TRITI aspect of the leader of expectations, but

38
00:02:04,440 --> 00:02:07,360
Speaker 2: overall I think they know that change is happening and

39
00:02:07,400 --> 00:02:08,440
Speaker 2: that it needs to happen.

40
00:02:09,000 --> 00:02:11,480
Speaker 1: Welcome R. Holland's Patient Advocate. Thank you very much for

41
00:02:11,480 --> 00:02:13,919
Speaker 1: your time this morning. Chair of Patient Voice Out had

42
00:02:13,960 --> 00:02:17,560
Speaker 1: eye for more from News Talks ed B listen live

43
00:02:17,760 --> 00:02:20,480
Speaker 1: on air or online, and keep our shows with you

44
00:02:20,560 --> 00:02:23,520
Speaker 1: wherever you go with our podcasts on Irradio